secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition II Corp. (DMII)
CIK:        0002040475
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024763
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Drugs Made In America Acquisition II confirms trust account of ~$507.8M after sponsor irregularities
--------------------------------------------------------------------------------

- Sponsor made improper withdrawals from working capital between Sep 26, 2025 IPO and Dec 31, 2025.
- Board confirmed irregularities did not affect trust account.
- As of March 6, 2026, trust account balance is approximately $507,841,957.
- The trust account protects public shareholders; no prior disclosure of exact balance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/0001213900-26-024763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/ea028047201-8k_drugs2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer